We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$7.36B
AUM Growth
+$457M
Cap. Flow
-$178M
Cap. Flow %
-2.42%
Top 10 Hldgs %
26.1%
Holding
2,906
New
66
Increased
422
Reduced
1,573
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 25.69%
2 Consumer Discretionary 12.47%
3 Healthcare 12.1%
4 Financials 11.43%
5 Communication Services 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LAZ icon
2551
Lazard
LAZ
$4.43B
$87K ﹤0.01%
1,994
+5
+0.3% +$234
ONIT
2552
Onity Group
ONIT
$330M
$86.6K ﹤0.01%
+2,167
New +$73.2K
BW icon
2553
Babcock & Wilcox
BW
$1.39B
$86.2K ﹤0.01%
9,561
+3,452
+57% +$27.7K
FIGS icon
2554
FIGS
FIGS
$2.47B
$86.1K ﹤0.01%
3,124
+1,925
+161% +$63.4K
CRBU icon
2555
Caribou Biosciences
CRBU
$160M
$86K ﹤0.01%
5,697
IRMD icon
2556
iRadimed
IRMD
$1.11B
$86K ﹤0.01%
+1,860
New +$75K
SMMF
2557
DELISTED
Summit Financial Group, Inc.
SMMF
$85.9K ﹤0.01%
3,129
SCU
2558
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$85.7K ﹤0.01%
4,012
-2,076
-34% -$47.4K
BDSI
2559
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$85.6K ﹤0.01%
27,621
+4,666
+20% +$15.7K
TACO
2560
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
$85.6K ﹤0.01%
6,872
-1,521
-18% -$14.7K
CHPT icon
2561
ChargePoint
CHPT
$160M
$85K ﹤0.01%
223
+119
+114% +$52.7K
EVCM icon
2562
EverCommerce
EVCM
$1.79B
$84.9K ﹤0.01%
5,390
SPB icon
2563
Spectrum Brands
SPB
$2.09B
$84.8K ﹤0.01%
834
+2
+0.2% +$196
TSHA icon
2564
Taysha Gene Therapies
TSHA
$1.92B
$84.8K ﹤0.01%
7,280
NDLS icon
2565
Noodles & Co
NDLS
$100M
$84.5K ﹤0.01%
1,165
-104
-8% -$9.47K
CMRX
2566
DELISTED
Chimerix, Inc.
CMRX
$84.3K ﹤0.01%
13,115
+3,295
+34% +$19.8K
MPAA icon
2567
Motorcar Parts of America
MPAA
$235M
$84.2K ﹤0.01%
4,935
HHH icon
2568
Howard Hughes
HHH
$4.04B
$84.2K ﹤0.01%
868
+3
+0.3% +$263
NWPX icon
2569
NWPX Infrastructure Inc
NWPX
$1.11B
$84.1K ﹤0.01%
2,646
AXS icon
2570
AXIS Capital
AXS
$7.3B
$84.1K ﹤0.01%
1,544
+4
+0.3% +$207
TNYA icon
2571
Tenaya Therapeutics
TNYA
$164M
$84K ﹤0.01%
4,431
KPTI icon
2572
Karyopharm Therapeutics
KPTI
$45.1M
$83.5K ﹤0.01%
865
+96
+12% +$9.57K
UFI icon
2573
UNIFI
UFI
$120M
$83.5K ﹤0.01%
3,605
LAB icon
2574
Standard BioTools
LAB
$294M
$82.8K ﹤0.01%
21,112
+3,910
+23% +$18.3K
GNTY
2575
DELISTED
Guaranty Bancshares
GNTY
$82.6K ﹤0.01%
2,199

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 Portfolio in Review

As of Q4 2021, Metropolitan Life Insurance Company (MetLife) held 2,906 positions worth $7.36B, up 6.6% from $6.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 filing shows 66 new, 422 increased, 1,573 reduced and 124 closed positions. Its largest new stake was Kyndryl: 32,951 shares worth $596K. The largest sale was iShares Russell 1000 Growth ETF, an estimated $18.3M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2021 buy was Kyndryl: 32,951 shares worth $596K.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $34.8M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $18.3M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Kansas City Southern in Q4 2021, selling an estimated $3.18M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 26% of its $7.36B portfolio in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 66 new positions and closed 124 in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.6% quarter-over-quarter to $7.36B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.